PATENT CLAIM ANALYSIS

Application Number: 15916171
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["536", "024100"]

Abstract:
The present disclosure generally relates to novel polynucleotide molecules for use in regulating gene expression in recombinant cells, such as labyrinthulomycetes cells. The disclosure further relates to nucleic acid constructs, such as vectors and expression cassettes, containing a regulatory element operably linked to a heterologous nucleotide sequence. The disclosure further relates to methods for stably transforming a host cell, such as a labyrinthulomycetes cell with transgenes. Stably transformed recombinant cells, progeny, biomaterials derived therefrom, and methods for preparing and using the same are also provided.

Claim (Index 10):
The nucleic acid construct of  claim 9 , wherein the terminator comprises a sequence having at least 90% sequence identity to a sequence selected from the group consisting of SEQ ID NOs:71-78.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.65517
- Patent Class: 536.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15056857', '14637356', '13693585', '15365844', '13871737']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7031857495578747
- 35 USC 102 Novelty (BERT): 0.6733156485770375
- Combined Prediction Score: 0.700198739459791
- Mean Citation Score: 431.95312
- Max Citation Score: 708.8836
- Similarity Product: 664.176044265318

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test